• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经原纤维缠结(NFTs)中磷酸化神经元中间丝蛋白的直接证据:阿尔茨海默病 NFTs 的磷酸化蛋白质组学。

Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs.

机构信息

Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

FASEB J. 2011 Nov;25(11):3896-905. doi: 10.1096/fj.11-181297. Epub 2011 Aug 9.

DOI:10.1096/fj.11-181297
PMID:21828286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3205835/
Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by brain pathology of intracellular neurofibrillary tangles (NFTs) and extracellular amyloid plaques. NFTs contain aberrantly hyperphosphorylated Tau as paired helical filaments (PHFs). Although NFs have been shown immunohistologically to be part of NFTs, there has been debate that the identity of NF proteins in NFTs is due to the cross-reactivity of phosphorylated NF antibodies with phospho-Tau. Here, we provide direct evidence on the identity of NFs in NFTs by immunochemical and mass spectrometric analysis. We have purified sarkosyl-insoluble NFTs and performed liquid chromatography/tandem mass spectrometry of NFT tryptic digests. The phosphoproteomics of NFTs clearly identified NF-M phosphopeptides SPVPKSPVEEAK, corresponding to Ser685, and KAESPVKEEAVAEVVTITK, corresponding to Ser736, and an NF-H phosphopeptide, EPDDAKAKEPS*KP, corresponding to Ser942. Western blotting of purified tangles with SMI31 showed a 150-kDa band corresponding to phospho-NF-M, while RT97 antibodies detected phospho-NF-H. The proteomics analysis also identified an NF-L peptide (ALYEQEIR, EAEEEKKVEGAGEEQAAAK) and another intermediate filament protein, vimentin (FADLSEAANR). Mass spectrometry revealed Tau phosphopeptides corresponding to Thr231, Ser235, Thr181, Ser184, Ser185, Thr212, Thr217, Ser396, and Ser403. And finally, phosphopeptides corresponding to MAP1B (corresponding to Ser1270, Ser1274, and Ser1779) and MAP2 (corresponding to Thr350, Ser1702, and Ser1706) were identified. In corresponding matched control preparations of PHF/NFTs, none of these phosphorylated neuronal cytoskeletal proteins were found. These studies independently demonstrate that NF proteins are an integral part of NFTs in AD brains.

摘要

阿尔茨海默病(AD)是一种神经退行性疾病,其特征是脑内存在神经原纤维缠结(NFTs)和细胞外淀粉样斑块的病理学变化。NFTs 包含异常过度磷酸化的 Tau 作为双螺旋丝(PHFs)。尽管 NFTs 的神经丝已经通过免疫组织化学显示为 NFTs 的一部分,但一直存在争议,即 NFTs 中的 NF 蛋白的身份是由于磷酸化 NF 抗体与磷酸化 Tau 的交叉反应。在这里,我们通过免疫化学和质谱分析提供了 NFTs 中 NF 的确切证据。我们已经纯化了 Sarkosyl 不溶性 NFTs,并对 NFT 胰蛋白酶消化物进行了液相色谱/串联质谱分析。NFT 的磷酸化蛋白质组学清楚地鉴定了 NF-M 磷酸肽 SPVPKSPVEEAK,对应于 Ser685,以及 KAESPVKEEAVAEVVTITK,对应于 Ser736,以及 NF-H 磷酸肽 EPDDAKAKEPS*KP,对应于 Ser942。用 SMI31 对纯化的缠结进行 Western 印迹显示对应于磷酸化 NF-M 的 150 kDa 带,而 RT97 抗体检测到磷酸化 NF-H。蛋白质组学分析还鉴定了 NF-L 肽(ALYEQEIR,EAEEEKKVEGAGEEQAAAK)和另一种中间丝蛋白 vimentin(FADLSEAANR)。质谱揭示了对应于 Thr231、Ser235、Thr181、Ser184、Ser185、Thr212、Thr217、Ser396 和 Ser403 的 Tau 磷酸肽。最后,鉴定了对应于 MAP1B(对应于 Ser1270、Ser1274 和 Ser1779)和 MAP2(对应于 Thr350、Ser1702 和 Ser1706)的磷酸肽。在相应的 PHF/NFT 匹配对照制剂中,没有发现这些磷酸化神经元细胞骨架蛋白。这些研究独立地证明 NF 蛋白是 AD 大脑中 NFTs 的一个组成部分。

相似文献

1
Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs.神经原纤维缠结(NFTs)中磷酸化神经元中间丝蛋白的直接证据:阿尔茨海默病 NFTs 的磷酸化蛋白质组学。
FASEB J. 2011 Nov;25(11):3896-905. doi: 10.1096/fj.11-181297. Epub 2011 Aug 9.
2
Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.独特的阿尔茨海默病双螺旋丝特异性表位涉及特定位点的双重磷酸化。
Biochemistry. 1997 Jul 1;36(26):8114-24. doi: 10.1021/bi970380+.
3
Evidence for the association of protein 4.1 immunoreactive forms with neurofibrillary tangles in Alzheimer's disease brains.阿尔茨海默病大脑中蛋白质4.1免疫反应形式与神经原纤维缠结相关性的证据。
Brain Res. 1994 Sep 5;656(1):14-26. doi: 10.1016/0006-8993(94)91361-7.
4
Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.铝与成对螺旋丝tau蛋白的相互作用参与了阿尔茨海默病的神经纤维病理过程。
Gerontology. 1997;43 Suppl 1:16-23. doi: 10.1159/000213882.
5
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.特定的tau蛋白磷酸化位点与阿尔茨海默病中神经元细胞病理学的严重程度相关。
Acta Neuropathol. 2002 Jan;103(1):26-35. doi: 10.1007/s004010100423.
6
Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.阿尔茨海默病神经原纤维缠结包含有丝分裂特异性磷酸表位。
J Neurochem. 1996 Dec;67(6):2405-16. doi: 10.1046/j.1471-4159.1996.67062405.x.
7
Ganglioglioma with neurofibrillary tangles (NFTs): neoplastic NFTs share antigenic determinants with NFTs of Alzheimer's disease.
Acta Neuropathol. 1995;89(5):451-3. doi: 10.1007/BF00307651.
8
Identification of polypeptides in neurofibrillary tangles and total homogenates of brains with Alzheimer's disease by tandem mass spectrometry.通过串联质谱法鉴定阿尔茨海默病患者脑中神经原纤维缠结和总匀浆中的多肽。
J Alzheimers Dis. 2013;34(1):239-62. doi: 10.3233/JAD-121480.
9
Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.进行性核上性麻痹中的神经原纤维缠结含有与阿尔茨海默病PHFtau中鉴定出的相同的tau表位。
J Neuropathol Exp Neurol. 1996 May;55(5):534-9. doi: 10.1097/00005072-199605000-00006.
10
Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.铝在体内和体外均可改变阿尔茨海默病PHF tau蛋白的特性。
J Neurosci. 1994 Nov;14(11 Pt 2):7221-33. doi: 10.1523/JNEUROSCI.14-11-07221.1994.

引用本文的文献

1
Analysis of an innovative fluid biomarker panel for early prediction of progression independent of relapse activity in multiple sclerosis.用于早期预测多发性硬化症中与复发活动无关的病情进展的创新型液体生物标志物组合分析。
Mult Scler J Exp Transl Clin. 2025 Sep 12;11(3):20552173251372751. doi: 10.1177/20552173251372751. eCollection 2025 Jul-Sep.
2
MAP2 phosphorylation: mechanisms, functional consequences, and emerging insights.微管相关蛋白2(MAP2)磷酸化:机制、功能后果及新见解
Front Cell Neurosci. 2025 Jul 30;19:1610371. doi: 10.3389/fncel.2025.1610371. eCollection 2025.
3
Genome-wide association of tau neuroimaging and plasma biomarkers in adults with Down syndrome.唐氏综合征成人中tau神经影像学与血浆生物标志物的全基因组关联研究。
Alzheimers Dement. 2025 Jul;21(7):e70398. doi: 10.1002/alz.70398.
4
Inhibition of Glycogen Synthase Kinase and the Neuroprotective Function of Conjugated ZnO-Osthol Nanoparticles in Alzheimer's Disease.糖原合酶激酶的抑制作用以及共轭氧化锌-蛇床子素纳米颗粒在阿尔茨海默病中的神经保护功能
Bioinorg Chem Appl. 2022 Sep 21;2022:1401995. doi: 10.1155/2022/1401995. eCollection 2022.
5
Molecular mechanisms and therapeutic potential of lithium in Alzheimer's disease: repurposing an old class of drugs.锂盐在阿尔茨海默病中的分子机制及治疗潜力:旧有药物类型的重新利用
Front Pharmacol. 2024 Jul 11;15:1408462. doi: 10.3389/fphar.2024.1408462. eCollection 2024.
6
Neurofilament Biophysics: From Structure to Biomechanics.神经丝生物物理学:从结构到生物力学。
Mol Biol Cell. 2024 May 1;35(5):re1. doi: 10.1091/mbc.E23-11-0438. Epub 2024 Apr 10.
7
Role of Cytoskeletal Elements in Regulation of Synaptic Functions: Implications Toward Alzheimer's Disease and Phytochemicals-Based Interventions.细胞骨架成分在调节突触功能中的作用:对阿尔茨海默病和基于植物化学物质干预的意义。
Mol Neurobiol. 2024 Oct;61(10):8320-8343. doi: 10.1007/s12035-024-04053-3. Epub 2024 Mar 16.
8
MAP2 caps tau fibrils and inhibits aggregation.MAP2 结合 tau 纤维并抑制聚集。
J Biol Chem. 2023 Jul;299(7):104891. doi: 10.1016/j.jbc.2023.104891. Epub 2023 Jun 5.
9
Proteomics analysis of prefrontal cortex of Alzheimer's disease patients revealed dysregulated proteins in the disease and novel proteins associated with amyloid-β pathology.阿尔茨海默病患者前额叶皮层的蛋白质组学分析揭示了疾病中失调的蛋白质和与淀粉样β病理相关的新蛋白质。
Cell Mol Life Sci. 2023 May 7;80(6):141. doi: 10.1007/s00018-023-04791-y.
10
Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.基于网络药理学和实验验证的开心散治疗阿尔茨海默病的作用机制
Chin J Integr Med. 2023 May;29(5):413-423. doi: 10.1007/s11655-022-3589-5. Epub 2022 Dec 7.

本文引用的文献

1
Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ.利用 iTRAQ 对阿尔茨海默病神经元中间丝蛋白(NF-M/H)进行定量磷酸化蛋白质组学分析。
FASEB J. 2010 Nov;24(11):4396-407. doi: 10.1096/fj.10-157859. Epub 2010 Jul 12.
2
Regulation of phosphorylation at the postsynaptic density during different activity states of Ca2+/calmodulin-dependent protein kinase II.在 Ca2+/钙调蛋白依赖性蛋白激酶 II 的不同活性状态下调节突触后密度处的磷酸化。
Biochem Biophys Res Commun. 2010 Jan 1;391(1):78-84. doi: 10.1016/j.bbrc.2009.10.167. Epub 2009 Nov 5.
3
Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau.海马旁回皮质中的过度磷酸化tau蛋白会损害表达野生型人类tau蛋白的老年小鼠的空间学习能力。
EMBO J. 2007 Dec 12;26(24):5143-52. doi: 10.1038/sj.emboj.7601917. Epub 2007 Nov 15.
4
Global profiling of phosphopeptides by titania affinity enrichment.通过二氧化钛亲和富集对磷酸化肽段进行全局分析。
J Proteome Res. 2007 Dec;6(12):4684-9. doi: 10.1021/pr070481m. Epub 2007 Oct 12.
5
Kinase activities increase during the development of tauopathy in htau mice.在htau小鼠的tau蛋白病发展过程中,激酶活性增加。
J Neurochem. 2007 Dec;103(6):2256-67. doi: 10.1111/j.1471-4159.2007.04930.x. Epub 2007 Oct 1.
6
Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis.来自阿尔茨海默病大脑的tau蛋白中的新磷酸化位点支持酪蛋白激酶1在疾病发病机制中的作用。
J Biol Chem. 2007 Aug 10;282(32):23645-54. doi: 10.1074/jbc.M703269200. Epub 2007 Jun 11.
7
Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases.在神经退行性疾病药物设计中解析tau蛋白过度磷酸化问题
Nat Rev Drug Discov. 2007 Jun;6(6):464-79. doi: 10.1038/nrd2111.
8
Caspase-3 cleaved spectrin colocalizes with neurofilament-immunoreactive neurons in Alzheimer's disease.在阿尔茨海默病中,半胱天冬酶-3切割的血影蛋白与神经丝免疫反应性神经元共定位。
Neuroscience. 2006 Aug 25;141(2):863-874. doi: 10.1016/j.neuroscience.2006.04.041. Epub 2006 Jun 5.
9
Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity.过度磷酸化的tau聚合成细丝会消除其抑制活性。
Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8864-9. doi: 10.1073/pnas.0603214103. Epub 2006 May 30.
10
Tau phosphorylation in neuronal cell function and dysfunction.神经元细胞功能与功能障碍中的tau蛋白磷酸化
J Cell Sci. 2004 Nov 15;117(Pt 24):5721-9. doi: 10.1242/jcs.01558.